Analysis of prostate MRI-fusion guided biopsies databases and comparison with multi centric results in the US to evaluate the value of different MRI-fusion techniques to detect prostate cancer
Analysis of prostate MRI-fusion guided biopsies databases and comparison with multi centric results in the US to evaluate the value of different MRI-fusion techniques to detect prostate cancer
批准号:
391093592
负责人:
Dr. Sebastian Berg
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2017
资助国家:
德国
项目状态:
已结题
起止时间:
2016-12-31 至 2017-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The topic of my research project is about validation of new diagnostic methods to detect prostate cancer (PCa). According to current guidelines, biopsy of the prostate (PBx) with following pathological examination is obligatory to ensure the diagnosis of PCa. But, PBx has risks and complications, like bleeding and infection. Therefore, unnecessary and repeated biopsies should be avoided and furthermore, the way of gaining tissue samples should be optimized to increase the accuracy of biopsies. Reasons for a systematic PBx are an elevated PSA-value (Prostate-specific antigen, PSA) or a suspicious abnormality in digital rectal examination. A new approach for targeted biopsy is the magnet resonance imaging-fusion guided prostate biopsy (MRI-fusion biopsy). First, the patient gets MRI of the prostate, which is reviewed by a radiologist and valued by a specific classification system called PIRADS (Prostate Imaging-Reporting and Data System). Afterwards you can take - for example guided by transrectal ultrasound - targeted biopsies of the suspicious lesions seen in the MRI. This method reaches a better accuracy and increases the probability of detecting PCa.Unfortunately, data varies concerning sensitivity and specificity of the MRI to detect a PCa. The main question is if you can avoid a biopsy when the MRI is inconspicuous. Furthermore, it is necessary to evaluate the use and help of MRI in treatment and management of low-risk tumors (Active Surveillance therapy). The importance of MRI prostate for the local treatment of PCa isn’t well examined, so this scope of tasks should be treated soon. MRI-fusion biopsy could be the future of target biopsies but there are still problems and questions which should be answered. For that reason, I want to do a Research Fellowship at Brigham and Women’s Hospital, Harvard Medical School, to focus on this important subject and to compare our outcomes with the results of the big US data. The findings and results of my research project could influence future guidelines and our understanding of the best possible way in detecting PCa.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Evaluation of magnetic resonance imaging and targeted biopsy: The difficulty of finding the right reference standard
磁共振成像和靶向活检的评估:寻找正确参考标准的困难
DOI:
10.1002/cncr.31201
发表时间:
2018
期刊:
Cancer
影响因子:
6.2
作者:
[Berg S, Fletcher SA, Cole AP, Trinh QD]
通讯作者:
Trinh QD
The new frontier of prostate biopsy: determining the role of image‐guidance in moving the needle
前列腺活检的新前沿:确定图像引导在移动针中的作用
DOI:
10.1111/bju.14052
发表时间:
2018
期刊:
BJU International
影响因子:
4.5
作者:
[Fletcher SA, Berg S, Trinh QD]
通讯作者:
Trinh QD
国内基金
海外基金
登录
查看更多内容
ELL在前列腺癌发生中的负性作用机制及其临床意义
-
批准号:81101948
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:刘凌琪
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
miRNA let-7a下调IGF1R抑制前列腺癌细胞雄激素非依赖性生长的作用机制
-
批准号:81071720
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:姜安丽
-
依托单位:
前列腺癌冷冻消融后HMGB1调节冷冻免疫反应相关机制研究
-
批准号:81001002
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:司同国
-
依托单位:
晚期糖基化终产物受体与视网膜母细胞瘤蛋白在前列腺癌细胞中的相互作用及意义
-
批准号:30700835
-
项目类别:青年科学基金项目
-
资助金额:16.0万元
-
批准年份:2007
-
负责人:赵善超
-
依托单位:
Kallikrein 4(KLK4)受激素调控的机制和对激素非依赖前列腺癌生长影响的实验研究
-
批准号:30571853
-
项目类别:面上项目
-
资助金额:27.0万元
-
批准年份:2005
-
负责人:席志军
-
依托单位: